G

GRCE

GRCE

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
17%Bearish
Buy/Sell Ratio100% buys
BearishBullish
GRCE Live QuoteReal-time
$1.73
$0.25(-12.63%)1M
Day Range$1.70 – $1.76
Open$1.73
Previous Close$1.72
Volume27.7K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$36.39M
P/E Ratio (TTM)24.5
Forward P/E2.2
EPS (TTM)$-1.16
Price to Book0.6
Dividend Yield0.65%
Beta (Volatility)0.41
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $1.73 (3%)
Low: $1.64High: $5.18
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$5.82-96.1% upside

Insider Buys

1

$136K

Insider Sales

0

$0

Total Volume

$136K

6 transactions

Net Activity

+$136K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys5 sells

$151.48B total

O
2

Opaleye Management Inc.

10%

1 buys0 sells

$136K total

Trading History
GRCE insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 14, 2026

1 months ago

Opaleye Management Inc.

10%

10% Owner
Buy71.1K$1.92$136K

Sep 29, 2026

1 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.80M$7849.00$21.96B

Sep 21, 2026

1 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.86M$15089.00$43.08B

Sep 8, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.78M$15229.00$42.26B

Sep 9, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell121.4K$100000.00$12.14B

Aug 14, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.76M$11608.00$32.04B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
GRCE Buy Conviction100%
Industry Rank#0 of 563
Volume Contribution0.0%
Total Industry Activity$16.73B

GRCE has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for GRCE

Over the last 90 days, corporate insiders at GRCE (GRCE) engaged in a total of 6 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $136K.

The net insider activity for GRCE shows a net buying bias of $136K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 2.86M shares valued at $43.08B on Sep 21, 2026.

Live Market News & Developments
Aggregated real-time headlines for GRCE (GRCE)
6 updates

Grace Therapeutics (GRCE) 10% owner Opaleye Management bought 48,060 shares for $83.4K at an average $1.74

Quantisnow17h ago

Opaleye Management buys $83,435 in Grace Therapeutics stock

Investing.com16h ago

Across three purchases, Opaleye, L.P. bought 48,060 shares of Grace Therapeutics (GRCE).

Stock Titan17h ago

GRCE - Grace Therapeutics Inc Stock Price and Quote

Finviz172d ago

GRCE Stock Price and Chart — NASDAQ:GRCE

TradingView212d ago

FDA declines Grace's stroke drug over manufacturing and packaging issues, shares slump

Reuters210d ago

FAQs About GRCE Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for GRCE.

Based on SEC Form 4 disclosures, the Insider Confidence Score for GRCE is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for GRCE is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.